Safety of Antibiotics During Breastfeeding

Antibiotic Classification and Safety

The European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) guidelines classify azithromycin as "probably safe" during breastfeeding 1
Cephalosporins, including ceftriaxone, are considered "compatible" with breastfeeding 2
Azithromycin and ceftriaxone are considered safe to use during breastfeeding, with azithromycin classified as "probably safe" and ceftriaxone as "compatible" according to current guidelines 1, 2

Infant Risk and Monitoring

There is a very low risk of hypertrophic pyloric stenosis in infants exposed to macrolides during the first 13 days of breastfeeding, but this risk does not persist after 2 weeks 1
Breastfed infants should be monitored for gastrointestinal effects due to alteration of intestinal flora 3
Antibiotics in breast milk could potentially cause falsely negative cultures if the breastfed infant develops a fever requiring evaluation 3

Important Considerations

The safety profile of antibiotics during breastfeeding assumes full-term, healthy infants, standard recommended doses and durations, and exclusive breastfeeding 4

Safe Antibiotics During Breastfeeding

Recommended Safe Antibiotics

The American Academy of Dermatology recommends amoxicillin/clavulanic acid as a safe and effective choice during breastfeeding, classified as FDA Category B and compatible with breastfeeding 5
The American Academy of Dermatology suggests azithromycin and erythromycin as safe alternatives, particularly for penicillin-allergic patients 5
Rifampin can be used with an approach similar to other patient populations, as recommended by the American Academy of Dermatology 5
Metronidazole is suggested as safe during breastfeeding, according to the American Academy of Dermatology 5

Antibiotics Requiring Caution

The American Academy of Dermatology advises to exercise caution with oral clindamycin as it may increase the risk of GI side effects in the infant 5
The American Academy of Dermatology recommends limiting oral doxycycline use to 3 weeks maximum without repeating courses; use only if no suitable alternative is available 5

Antibiotic Use During Breastfeeding

Safe Antibiotic Options

The American Academy of Dermatology recommends amoxicillin/clavulanic acid as a safe and effective choice during breastfeeding 6, 7, 8
Cephalosporins, including cephalexin and ceftriaxone, are considered compatible with breastfeeding by the European Respiratory Society 8
Azithromycin is classified as "probably safe" during breastfeeding, according to the American Academy of Dermatology and European Respiratory Society 6, 8
Erythromycin is suggested as safe, particularly for penicillin-allergic patients, by the American Academy of Dermatology 6
Metronidazole is suggested as safe during breastfeeding by the American Academy of Dermatology 6, 7

Antibiotics Requiring Caution

Clindamycin should be used with caution as it may increase the risk of GI side effects in the infant, according to the American Academy of Dermatology 6, 7
Doxycycline use should be limited to 3 weeks maximum without repeating courses, as recommended by the European Respiratory Society and American Academy of Dermatology 6, 8
Co-trimoxazole should be avoided in premature babies, jaundiced infants, or those with G6PD deficiency, according to the European Respiratory Society 8

Monitoring Considerations

There is a very low risk of hypertrophic pyloric stenosis in infants exposed to macrolides during the first 13 days of breastfeeding, but this risk does not persist after 2 weeks, as reported by the European Respiratory Society 8
All breastfed infants should be monitored for gastrointestinal effects due to alteration of intestinal flora, according to the European Respiratory Society 8
Antibiotics in breast milk could potentially cause falsely negative cultures if the breastfed infant develops fever requiring evaluation, as noted by the European Respiratory Society 8

Amoxicillin Use During Breastfeeding

Safety Profile

The European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) guidelines classify amoxicillin as compatible with breastfeeding 9
Amoxicillin is classified as FDA Category B and is explicitly listed as "compatible" with breastfeeding by multiple international guidelines, including the European Respiratory Society 9

Transfer to Breast Milk

Research confirms that penicillins and aminopenicillins, including amoxicillin, are present in breast milk at low concentrations 9

Infant Monitoring Considerations

All breastfed infants whose mothers are taking antibiotics, including amoxicillin, should be monitored for gastrointestinal effects, though serious adverse events are rare 9
Antibiotics in breast milk, such as amoxicillin, may alter intestinal flora, potentially causing mild diarrhea or gastroenteritis in the infant 9

Clinical Recommendations

The European Respiratory Society guidelines suggest that breastfeeding should not be interrupted when amoxicillin is prescribed, as the benefits of continued breastfeeding outweigh the minimal risks of amoxicillin exposure through breast milk 9

Common Pitfall to Avoid

The European Respiratory Society guidelines recommend caution when using amoxicillin/clavulanic acid in women at risk of pre-term delivery due to a very low risk of necrotizing enterocolitis, but amoxicillin alone is considered safe 9

Antibiotic Use in Lactating Mothers

Safe Antibiotic Options

The European Respiratory Society recommends amoxicillin as a primary choice for breastfeeding mothers, as it is explicitly classified as "compatible" with breastfeeding 10
Cephalexin and other first-generation cephalosporins are "compatible" with breastfeeding and recommended for skin/soft tissue infections, according to the European Respiratory Society 10
Azithromycin is classified as "probably safe" but should ideally be avoided during the first 13 days postpartum, as recommended by the European Respiratory Society 10
Aztreonam (inhaled) has minimal systemic absorption and is safe for use during breastfeeding, as stated by the European Respiratory Society 10

Antibiotics Requiring Caution

Doxycycline and other tetracyclines should be limited to 3 weeks maximum without repeating courses, as recommended by the European Respiratory Society 10
Short-term tetracycline use (3-4 weeks) is compatible with breastfeeding, but avoid longer courses due to potential tooth discoloration and bone growth suppression, according to the European Respiratory Society 10
Co-trimoxazole should be avoided in premature infants, jaundiced babies, or those with G6PD deficiency, as recommended by the European Respiratory Society 10

Essential Monitoring Considerations

All breastfed infants should be monitored for gastrointestinal effects (diarrhea, gastroenteritis) due to alteration of intestinal flora, as recommended by the European Respiratory Society 10
Antibiotics in breast milk could cause falsely negative cultures if the infant develops fever requiring evaluation, according to the European Respiratory Society 10
Fluoroquinolones (ciprofloxacin, levofloxacin) should not be used as first-line treatment during breastfeeding, but if absolutely necessary, ciprofloxacin is the preferred fluoroquinolone, as stated by the European Respiratory Society 10

Augmentin Use During Breastfeeding

Safety and Efficacy

The American Journal of Respiratory and Critical Care Medicine notes that the small amounts of antibiotic in breast milk should not be considered therapeutic for the infant—if the baby develops an infection, they require their own appropriate dosing 11

Pharmacokinetics in Infants

No additional facts are available with a citation id.

Antibiotic Use in Breastfeeding Mothers

Safe Antibiotic Options

The Centers for Disease Control and Prevention, as reported in the MMWR Recommendations and Reports, suggests that if fluoroquinolones are necessary, ciprofloxacin is the preferred option due to its lower concentration in breast milk, two orders of magnitude lower than therapeutic infant doses 12

Special Considerations for Infant Exposure

In cases of bioterrorism exposure, such as anthrax or plague, the American Academy of Pediatrics, as published in Emerging Infectious Diseases, recommends that the breastfeeding mother's antimicrobial regimen should match the infant's regimen when possible, to ensure both are protected 13
If regimen matching is not possible, the mother can pump and discard breast milk during treatment and resume breastfeeding after completing prophylaxis, as suggested by the Centers for Disease Control and Prevention, in collaboration with the World Health Organization, and reported in Emerging Infectious Diseases 13

Safe Antibiotics for Breastfeeding Patients

First-Line Safe Antibiotics

The American Academy of Dermatology recommends amoxicillin/clavulanic acid as safe and effective during breastfeeding, with high-quality evidence supporting its use 14
Erythromycin is suggested as safe for breastfeeding patients, particularly for those with penicillin allergies 14
Metronidazole is suggested as safe for breastfeeding patients 14
Rifampin can be used with an approach similar to other patient populations during breastfeeding 14

Antibiotics Requiring Caution

Clindamycin should be used with caution in breastfeeding patients as it may increase the risk of GI side effects in the infant, including diarrhea, candidiasis, or rarely antibiotic-associated colitis 14
Doxycycline use should be limited to 3 weeks maximum without repeating courses in breastfeeding patients, and only if no suitable alternative is available 14

Amoxicillin Use During Breastfeeding

Safety Classification and Evidence

The European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) guidelines and the American Academy of Dermatology classify amoxicillin as "compatible" with breastfeeding, representing the highest level of safety designation for antibiotics during lactation, with a high level of evidence 15
The FDA classifies amoxicillin as Pregnancy Category B, and the drug label confirms that penicillins are excreted in human milk, though caution should be exercised, based on moderate evidence 15

Clinical Recommendations

The American Academy of Dermatology recommends that amoxicillin/clavulanic acid (Augmentin) is considered safe and effective during breastfeeding, classified as FDA Category B and compatible with nursing, with a moderate level of evidence 15

Dosing Considerations

Standard adult dosing of amoxicillin is 250 mg twice daily up to 500 mg three times daily, according to the American Academy of Dermatology, with a high level of evidence 15

Co-amoxiclav Safety During Breastfeeding

Safety Classification

The European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) guidelines and the American Academy of Dermatology classify co-amoxiclav as "compatible" with breastfeeding, representing the highest safety designation for antibiotics during lactation 16

Infant Monitoring Considerations

All breastfed infants whose mothers are taking co-amoxiclav should be monitored for mild gastrointestinal effects, though serious adverse events are rare, and antibiotics in breast milk may alter intestinal flora, potentially causing mild diarrhea or gastroenteritis in the infant 16

Important Caveats

Amoxicillin/clavulanic acid should not be used in women at risk of pre-term delivery due to a very low risk of necrotizing enterocolitis in the fetus, but for breastfeeding after term delivery, co-amoxiclav remains fully compatible and safe 16
This caveat applies to pregnancy/delivery contexts, not to postpartum breastfeeding in term infants, and co-amoxiclav remains a safe choice for breastfeeding mothers after term delivery 16

Clindamycin Use During Breastfeeding

Safety Considerations

The American Academy of Dermatology advises that topical clindamycin formulations result in significantly lower systemic absorption compared to oral administration, making them a safer option if clindamycin is specifically indicated, with caution advised due to unknown excretion in human milk after topical application 17
Topical clindamycin used in acne treatment has lower infant exposure due to minimal systemic absorption, and is considered a safer option compared to oral clindamycin 17

Clinical Decision Making

When clindamycin is specifically indicated, consider using a topical formulation if treating a localized infection, to minimize infant exposure 17

Cefixime Safety in Breastfeeding Mothers

Class-Based Safety Evidence

β-lactam antibiotics, including cephalosporins, are commonly used and overall thought to be safe during lactation, with the Mayo Clinic guidelines noting they are generally safe, in contrast to tetracyclines and fluoroquinolones which should be avoided 18, 19
The Mayo Clinic guidelines specifically recommend that β-lactam antibiotics are safe for use during lactation, according to the Mayo Clinic 18, 19

Cephalosporin-Specific Data

Ceftazidime and ceftriaxone, other third-generation cephalosporins like cefixime, are classified as "compatible" with breastfeeding, according to the European Respiratory Society 20
Most studies found that cephalosporin antibiotics in general are safe to use during lactation, with low presence in breast milk, as reported in the European Respiratory Journal 20

Clinical Decision Algorithm

First-line alternatives, such as cephalosporins with established lactation safety data, like cephalexin and ceftriaxone, are explicitly classified as "compatible" with breastfeeding, according to the European Respiratory Journal 20

Cefixime Safety in Breastfeeding Mothers

Evidence-Based Safety Assessment

The American Academy of Pediatrics and other international societies consider β-lactam antibiotics, including all cephalosporins, to be safe during lactation, representing the highest level of guideline consensus 21

Clinical Decision Algorithm

When treating a breastfeeding mother requiring a cephalosporin, the European Respiratory Society classifies third-generation cephalosporins, such as ceftriaxone, as "compatible" with breastfeeding, and cefixime can be used based on class safety data 21

Resource for Verification

The National Institutes of Health's LactMed database is a peer-reviewed resource providing insights into potential adverse effects of drugs on nursing infants and should be consulted for the most current information 21

Safe Antibiotics for Breastfeeding Mothers with Diarrhea

Introduction to Safe Antibiotic Options

The American Academy of Pediatrics and other medical societies recommend that breastfeeding mothers with diarrhea should not discontinue breastfeeding unnecessarily, as short courses of antibiotics are commonly used and there is no evidence of harmful effects in breastfeeding women 22

First-Line Safe Antibiotic Options

The European Respiratory Society and American Academy of Dermatology are not cited, however, other societies may recommend β-lactam antibiotics, such as amoxicillin, as the safest choice for breastfeeding mothers with diarrhea, due to their minimal transfer to breast milk and limited impact on the nursing infant, however no citation is provided for this information

Alternative Safe Options

No alternative safe options are cited in the article

Clinical Decision Algorithm

No clinical decision algorithm is cited in the article

Common Pitfalls to Avoid

The Anaesthesia journal recommends that breastfeeding mothers with diarrhea should not discontinue breastfeeding unnecessarily, as short courses of antibiotics are commonly used and there is no evidence of harmful effects in breastfeeding women 22

Antibiotics for Breastfeeding Mothers with Chronic Periapical Abscess

Introduction to Antibiotic Selection

The World Health Organization recommends amoxicillin-clavulanate as an option for oral and dental infections, with the addition of metronidazole if treatment fails 23
For dental infections that fail with amoxicillin alone, the addition of clavulanate provides broader coverage against beta-lactamase-producing bacteria 23

Antibiotic Dosage and Duration

The standard dosage is 500 mg/125 mg three times a day or 875 mg/125 mg twice a day, with a treatment duration of 4-7 days if adequate source control (drainage) is achieved 24

Alternative Antibiotics for Penicillin Allergy

Clindamycin can be used but must be done with caution due to the potential risk of gastrointestinal side effects in the baby, including diarrhea and candidiasis, with an oral dose of 300-450 mg three times a day 23
Metronidazole is considered safe during breastfeeding and can be added for anaerobic coverage if necessary, with a dose of 500 mg three times a day 23

Monitoring and Precautions

All breastfed babies should be monitored for gastrointestinal effects (diarrhea, gastroenteritis) due to changes in gut flora 23

Safe Antibiotics for Breastfeeding Mothers

First-Line Recommended Antibiotics

The American Academy of Dermatology recommends amoxicillin/clavulanic acid as the best first-line antibiotic for breastfeeding mothers, with the strongest evidence supporting its safety and efficacy, classified as FDA Category B and explicitly "compatible" with nursing 25
Azithromycin is classified as "probably safe" and serves as a good alternative, especially for penicillin-allergic patients, according to the American Academy of Dermatology 25
Erythromycin is suggested as safe during breastfeeding, particularly for penicillin-allergic mothers, by the American Academy of Dermatology 25
Metronidazole is considered safe and can be added for enhanced anaerobic coverage when needed, as recommended by the American Academy of Dermatology 25

Antibiotics Requiring Caution

The American Academy of Dermatology advises to exercise caution with oral clindamycin as it may increase the risk of GI side effects in the infant, including diarrhea, candidiasis, or rarely antibiotic-associated colitis 25
The American Academy of Dermatology recommends limiting doxycycline use to 3 weeks maximum without repeating courses, and only if no suitable alternative antibiotic is available 25

Clinical Decision Algorithm

The American Academy of Dermatology suggests starting with amoxicillin/clavulanic acid as first-line therapy unless contraindicated 25
If penicillin allergy exists, the American Academy of Dermatology recommends using azithromycin or erythromycin as safe alternatives 25
For infections requiring anaerobic coverage, the American Academy of Dermatology advises adding metronidazole to the regimen 25
The American Academy of Dermatology recommends avoiding clindamycin unless specifically indicated, and if used, monitoring infant closely for GI effects 25
The American Academy of Dermatology suggests reserving doxycycline only when no other suitable alternative exists, limiting use to 3 weeks maximum 25

Common Pitfalls to Avoid

The American Academy of Dermatology advises not to use oral clindamycin as first-line therapy when safer alternatives like amoxicillin/clavulanic acid are available 25
The American Academy of Dermatology recommends not to prescribe doxycycline as first-line therapy in breastfeeding patients given the availability of safer alternatives 25

Azithromycin Use in Breastfeeding Mothers and Infant Safety

Preferred Macrolide for Early Infancy

For infants younger than 1 month, azithromycin is recommended as the macrolide of choice when the mother requires antibiotic therapy, because it has not been linked to infantile hypertrophic pyloric stenosis (IHPS) unlike erythromycin. This recommendation is supported by the CDC’s MMWR Recommendations and Reports. 26

Parental Counseling and Risk Communication

Parents should be advised to watch for signs of IHPS—such as projectile vomiting and dehydration—if the mother uses azithromycin during the early postpartum period; however, the absolute risk of IHPS remains very low. Guidance is based on the CDC’s MMWR Recommendations and Reports. 27

Cefuroxime Use During Breastfeeding

Safety Classification and Maternal Guidance

Infant Monitoring Recommendations

Comparative Antibiotic Safety for Breastfeeding

Clinical Practice Guidance

Relative Infant Dose of Amoxicillin During Breastfeeding

Pharmacokinetic Safety

The relative infant dose (infant dose mg/kg/day ÷ maternal dose mg/kg/day) for amoxicillin is well below the 10 % threshold that defines safe exposure for nursing infants, indicating minimal risk from maternal therapy at standard adult dosing【29】. (Evidence level: observational pharmacokinetic study).

Evidence‑Based Antibiotic Recommendations for Breastfeeding Mothers

Beta‑Lactam Options

Ampicillin‑sulbactam is considered safe for use during lactation and offers coverage comparable to amoxicillin‑clavulanate, although it is generally reserved for intravenous administration. 30, 31

Recommended First‑Line Regimen

A 7‑ to 10‑day course of amoxicillin‑clavulanate (500 mg/125 mg three times daily or 875 mg/125 mg twice daily) provides comprehensive coverage of streptococci, many gram‑negative rods, and anaerobes in a single oral agent. 30

Management of Penicillin Allergy

In patients with a severe penicillin allergy, a combination of ciprofloxacin (500–750 mg twice daily) and metronidazole (500 mg three times daily) is recommended as an alternative regimen. 30

Fluoroquinolone Considerations

Moxifloxacin and levofloxacin deliver enhanced anaerobic and gram‑positive activity but are not advised as first‑line agents for breastfeeding mothers; they should be reserved for situations where no safer alternative exists. 32

Oral Clindamycin Use During Breastfeeding: Risks and Preferred Alternatives

Risk Assessment of Oral Clindamycin

Oral clindamycin may increase gastrointestinal adverse effects in breast‑fed infants, including diarrhea, oral or diaper candidiasis, and rarely antibiotic‑associated colitis; therefore caution is advised when prescribing it to nursing mothers. 33

Preferred Antibiotic Alternatives (Strong Evidence)

Amoxicillin/clavulanic acid is classified as FDA Category B and is explicitly “compatible” with breastfeeding, making it the preferred first‑line systemic antibiotic for nursing patients when clinically appropriate. Strong recommendation (American Academy of Dermatology, 2025). 33
Azithromycin is deemed “probably safe” for breastfeeding and is an excellent alternative for patients with penicillin allergy. Strong recommendation (American Academy of Dermatology, 2025). 33
Erythromycin is considered safe for nursing infants and is also suitable for penicillin‑allergic patients. Strong recommendation (American Academy of Dermatology, 2025). 33
Metronidazole is regarded as safe during lactation and can be used when indicated. Strong recommendation (American Academy of Dermatology, 2025). 33

Clinical Decision Algorithm (American Academy of Dermatology, 2025)

Step 1 – Indication Check: Determine whether clindamycin is specifically required for the infection or if an alternative antibiotic can provide equivalent coverage. 33
Step 2 – Use Alternatives When Possible:
- If clindamycin is not essential, prescribe amoxicillin/clavulanic acid as the first‑line therapy unless contraindicated. 33
- For patients with penicillin allergy, select azithromycin or erythromycin instead of clindamycin. 33
Step 3 – When Clindamycin Is Required (e.g., anaerobic infection, MRSA):
- Prefer topical clindamycin formulations for localized skin infections, which achieve markedly lower systemic absorption and thus reduce infant exposure. 34
- If oral clindamycin must be used, implement close monitoring of the infant for gastrointestinal symptoms.

Monitoring Recommendations

Infants breast‑fed by mothers receiving oral clindamycin should be observed for signs of gastrointestinal disturbance such as diarrhea, oral or diaper candidiasis, or blood in stool indicating possible colitis. Prompt parental counseling and reporting are essential.

Context from Public Health Guidelines

The CDC’s 2021 recommendations on plague treatment note that several antibiotic classes (aminoglycosides, fluoroquinolones, tetracyclines) appear in breast milk only in trace amounts; clindamycin is not specifically addressed, implying it is a less preferred option in emergency scenarios where safer alternatives exist. 35